In fact, MitoQ has been used in a range of in vivo studies, in rats and mice, and in two phase II human trials demonstrating that it can be safely delivered to patients with promising results, lending further support that mitochondria-targeted antioxidants may be applicable to a wide range of human pathologies that involve mitochondrial oxidative damage (Smith and Murphy, 2010)
For this reason, it is not FDA-approved and has raised concerns over its safety, with the FDA warning in 2024 it had received reports of hospitalizations and adverse effects from use of compounded semaglutide injections due to dosing errors
Pharmacol Biochem Behav 36:203205 Tudor M, Jandric I, Marovic A et al (2010) Traumatic brain injury in mice and pentadecapeptide BPC 157 effect
Based strictly on early trial comparisons, Retatrutide may achieve slightly greater weight loss (24% in 48 weeks) compared to Mounjaros 22% in 72 weeks
2 p value 50% was considered as significant heterogeneity and a random-effect model was used to estimate the combined MD or RR
Hydrate and check your electrolytes